{"SLR NAME":"CT features of Coronavirus disease 2019 in children: a systematic review and meta-analysis","References":[{"title1":"Clinical features of pediatric patients with coronavirus disease (COVID-19)","References":[{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study [J]","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China[J]","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"The International Committee on Taxonomy of Viruses (ICTV) Coronaviridae Study Group. Naming the 2019 Coronavirus. https://talk.ictvonline.org/.","References":[]},{"title2":"https://www.who.int/dg/speeches/detail/who-director-general-s-statement-on-ihr-emergency-committee-on-novel-coronavirus-(2019-ncov). Accessed 3/3/2020.","References":[]},{"title2":"WHO. Novel Coronavirus (2019-nCoV) Situation Report - 22[EB/OL](2020-02-11)[2020-02-11].https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/.","References":[]},{"title2":"A Novel Coronavirus from Patients with Pneumonia in China, 2019","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Inferring the hosts of coronavirus using dual statistical models based on nucleotide composition"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"2019 novel coronavirus (2019-nCoV) outbreak: a new challenge"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan"},{"title3":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China"},{"title3":"Novel Wuhan (2019-nCoV) coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus phylogeny: toward consensus"},{"title3":"Diagnosis and treatment of new coronavirus pneumonia (trial version 7) [J / OL]. Tianjin J Tradit Chin Med. 2020;1-5. http://kns.cnki.net/kcms/detail/12.1349.R.20200304.1638.006.html. Accessed 3 June 2020."},{"title3":"Clinical outcome of standardized oxygen therapy nursing strategy in COVID-19"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus"},{"title3":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection"},{"title3":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV"},{"title3":"Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients"},{"title3":"Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study"},{"title3":"C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early"},{"title3":"Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Human ipsc-derived cardiomyocytes are susceptible to Sars-Cov-2 infection"},{"title3":"Cardiovascular complications in COVID-19"},{"title3":"COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"}]},{"title2":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72,314 cases from the chinese center for disease control and prevention","References":[]},{"title2":"Clinical analysis of 31 cases of 2019 novel coronavirus infection in children from six provinces (autonomous region) of northern China","References":[]},{"title2":"Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center's observational study","References":[{"title3":"Diagnosis and treatment of 2019 novel coronavirus infection in children: a pressing issue"},{"title3":"National Health Commission of People's Republic of China. http://en.nhc.gov.cn/2020-02/24/c_76911.htm. Accessed 24 Feb 2020"},{"title3":"Pathogenicity and transmissibility of 2019-nCoV:a quick overview and comparison with other emerging viruses"},{"title3":"Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)"},{"title3":"Novel coronavirus infection in hospitalized infants under 1 year of age in China"},{"title3":"National Health Commission. Diagnosis and treatment of pneumonia caused by 2019-nCoV (trial version 6). https://baijiahao.baidu.com/s?id=1658945855347500695&amp;wfr=spider&amp;for=pc. Accessed 18 Feb 2020"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Transmission dynamics of 2019 novel coronavirus (2019-nCoV)"},{"title3":"Characteristics of and public health responses to the coronavirus disease 2019 outbreak in China"},{"title3":"Understanding of COVID-19 based on current evidence"},{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72,314 cases from the Chinese Center for Disease Control and Prevention"},{"title3":"Coronavirus: covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"2019-novel coronavirus infection in a three-month-old baby"},{"title3":"Recommendation for the diagnosis and treatment of novel coronavirus infection in children in Hubei (trial version 1)"},{"title3":"Effects of ageing on the immune system: infants to elderly"},{"title3":"New coronavirus: new challenges for pediatricians"},{"title3":"Epidemiologic characteristics of early cases with 2019 novel coronavirus (2019-nCoV) disease in republic of Korea"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series"},{"title3":"Clinical and epidemiological characteristics of 34 children with 2019 novel coronavirus infection in Shenzhen"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Reducing mortality from 2019-nCoV: host-directed therapies should be an option"},{"title3":"Severe acute respiratory syndrome: historical, epidemiologic, and clinical features"},{"title3":"The Middle East respiratory syndrome (MERS)"},{"title3":"Coronavirus infections and immune responses"},{"title3":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology"}]},{"title2":"Epidemiology of COVID-19 among children in China","References":[{"title3":"World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report - 83 [press release]. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200412-sitrep-83-covid-19.pdf?sfvrsn=697ce98d_4. Accessed April 12, 2020."},{"title3":"Epidemiology of COVID-19 among children in China"},{"title3":"Control and Prevention. Coronavirus Disease 2019 in Children : United States, February 12-April 2, 2020"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"SARS-CoV-2 infection in children"},{"title3":"Detection of COVID-19 in children in early January 2020 in Wuhan, China"},{"title3":"Novel coronavirus infection in hospitalized infants under 1 year of age in China"},{"title3":"Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding"},{"title3":"A 55-day-old female infant infected with COVID 19: presenting with pneumonia, liver injury, and heart damage"},{"title3":"Coronavirus infections in children including COVID-19: An overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children"},{"title3":"Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection"}]},{"title2":"Clinical and CT features in pediatric patients with COVID-19 infection: different points from adults","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Novel coronavirus (2019-nCoV) early-stage importation risk to Europe, January 2020"},{"title3":"General Office of the National Health Commission of China. Diagnosis and Treatment Protocol for 2019-nCoV. 5th ed. Beijing, China: National Health Commission of China; 2020."},{"title3":"Wuhan: Britons to be evacuated as scientists estimate 44 000 cases of 2019-nCOV in the city"},{"title3":"Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health:the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia"},{"title3":"Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis"},{"title3":"Chest CT findings in 2019 novel coronavirus (2019-nCoV) infections from Wuhan, China: key points for the radiologist"},{"title3":"Emerging coronavirus 2019-nCoV pneumonia"},{"title3":"Differentiation of bacterial and viral pneumonia in children"}]},{"title2":"Chest computed tomography in children with COVID-19 respiratory infection","References":[{"title3":"World Health Organization (2020) Coronavirus disease (COVID-19) outbreak. https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed 15 Feb 2020"},{"title3":"World Health Organization (2020) Novel coronavirus : China. https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/. Accessed 15 Feb 2020"},{"title3":"International Committee on Taxonomy Viruses (2020) Naming the 2019 coronavirus. https://talk.ictvonline.org/. Accessed 15 Feb 2020"},{"title3":"World Health Organization (2020) Novel coronavirus (2019-nCoV) situation report - 22. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200211-sitrep-22-ncov.pdf?sfvrsn=fb6d49b1_2. Accessed 15 Feb 2020"},{"title3":"World Health Organization (2020) Novel coronavirus (COVID-19) situation. https://experience.arcgis.com/experience/685d0ace521648f8a5beeeee1b9125cd. Accessed 4 March 2020"},{"title3":"Chung M, Bernheim A, Mei XY et al (2020) CT imaging features of 2019 novel coronavirus (2019-nCoV). Radiology. 10.1148/radiol.2020200230. Accessed 20 Feb 2020"},{"title3":"Xie XZ, Zhong Z, Zhao W et al (2020) Chest CT for typical 2019-nCoV pneumonia: relationship to negative RT-PCR testing. Radiology. 10.1148/radiol.2020200343. Accessed 20 Feb 2020"},{"title3":"Pan YY, Guan HX, Zhou SC et al (2020) Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China. Eur Radiol. 10.1007/s00330-020-06731-x. Accessed 20 Feb 2020"}]},{"title2":"Severe acute respiratory syndrome in children [J]","References":[]},{"title2":"Middle East respiratory syndrome coronavirus in children[J]","References":[]},{"title2":"Clinical features and high resolution CT imaging findings of preliminary diagnosis novel coronavirus pneumonia","References":[]},{"title2":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target","References":[{"title3":"https://www.clinicaltrialsarena.com/news/company-news/gilead-coronavirus-remdesivir-trial/"},{"title3":"Therapeutic options for the 2019 novel coronavirus (2019-nCoV)"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS"},{"title3":"https://www.nature.com/articles/d41586-020-00364-2"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its Spike protein for risk of human transmission"},{"title3":"Structure of SARS coronavirus Spike receptor-binding domain complexed with receptor"},{"title3":"Mechanisms of host receptor adaptation by severe acute respiratory syndrome coronavirus"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Mice transgenic from human angiotensin-converting enzyme 2 provide a model for SARS coronavirus infection"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Zhao Y, Zhao Z, Wang Y, Zhou Y, Ma Y, Zuo W (2020) Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan COVID-19. 10.1101/2020.01.26.919985"},{"title3":"Angiotensin-converting enzyme 2 is an essential regulator of heart function"},{"title3":"Essential role for collectrin in renal amino acid transport"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus: a first step in understanding SARS pathogenesis"},{"title3":"ACE2 links amino acid malnutrition to microbial ecology andf intestinal inflammation"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 2019 novel coronavirus infection in China"},{"title3":"https://www.cdc.gov/coronavirus/2019-ncov/about/transmission.html"},{"title3":"The novel coronavirus 2019 (COVID-19) uses the SARS-1 coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells"},{"title3":"Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus Spike protein for membrane fusion and reduces viral control by the humoral immune response"},{"title3":"TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection"},{"title3":"Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry"},{"title3":"Protease inhibitors targeting coronavirus and filovirus entry"},{"title3":"Angiotensin-(1-5), an active mediator of renin-angiotensin system, stimulates ANP secretion via Mas receptor"},{"title3":"Mechanical stress and the induction of lung fibrosis via the midkine signaling pathway"},{"title3":"Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist"},{"title3":"Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjects"},{"title3":"A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome"},{"title3":"Recombinant human ACE2: acing out angiotensin II in ARDS therapy"}]},{"title2":"Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin [EB / OL]","References":[]},{"title2":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission","References":[{"title3":"Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Evidence for a common evolutionary origin of coronavirus spike protein receptor-binding subunits"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"SWISSMODEL: an automated protein homology-modeling server"},{"title3":"GISAID: Global initiative on sharing all influenza data:from vision to reality"}]},{"title2":"Application of metabolomics in viral pneumonia treatment with traditional Chinese medicine","References":[{"title3":"Viral pneumonia"},{"title3":"Viral pneumonia: epidemiological, clinical, pathophysiological and therapeutic aspects"},{"title3":"Certain progress of clinical research on Chinese integrative medicine"},{"title3":"Metabolomics applied to pediatric diseases: opportunities and challenges"},{"title3":"Evaluation of TCM on children's respiratory syncytial virus pneumonia with&quot; wind and heat blocking the lung syndrome&quot; and&quot; phlegm-heat obstructing the lung syndrome&quot; by multi-center stratified randomization and equal control methods"},{"title3":"TCM treatment of infectious atypical pneumonia:a report of 16 cases"},{"title3":"Clinical Observation on 60 Patients with Acute Pneumonia (Type of Phlegm-Heat Obstructing Lungs) Treated by Tanreqing Injecion [J]"},{"title3":"Application of traditional Chinese medical herbs in prevention and treatment of respiratory syncytial virus"},{"title3":"Fatty acid metabolism is associated with disease severity after H7N9 infection"},{"title3":"Plasma metabolomics for the diagnosis and prognosis of H1N1 influenza pneumonia"},{"title3":"A metabonomic approach to the effect evaluation of treatment in patients infected with influenza A (H1N1)"},{"title3":"Meng X. Regularity of compound herbal formula for pneumonia treated by Professor Wang Shouchuan and anti-RSV effect of Jinxin oral liquid and baicalein based on metabolomics. NJUCM. 2017."},{"title3":"Lipidomics study on antiviral effects of baical skullcap root extraction based on liquid chromatography-mass spectrography"},{"title3":"Metabonomics study on the effect of Polygonum Cuspidatumon anti-respiratory syncytial virus (RSV) basing on lipid metabolism"},{"title3":"A metabolomics approach to studying the effects of Jinxin oral liquid on RSV-infected mice using UPLC/LTQ-Orbitrap mass spectrometry"},{"title3":"Traditional Chinese medicine: a brief outline"},{"title3":"Antiviral activities of medicinal herbs traditionally used in southern mainland China"},{"title3":"Ginseng diminishes lung disease in mice immunized with formalin-inactivated respiratory syncytial virus after challenge by modulating host immune responses"},{"title3":"Sheng-Ma-Ge-Gen-Tang (Shoma-kakkon-to) inhibited cytopathic effect of human respiratory syncytial virus in cell lines of human respiratory tract"},{"title3":"Antiviral activities of several oral traditional chinese medicines against influenza viruses"},{"title3":"Application of traditional chinese medical herbs in prevention and treatment of respiratory syncytial virus"},{"title3":"Baicalin from Scutellaria baicalensis blocks respiratory syncytial virus (RSV) infection and reduces inflammatory cell infiltration and lung injury in mice"},{"title3":"An enteric virus can replace the beneficial function of commensal bacteria"},{"title3":"Growing pains for metabolomics: the newest'omic science is producing results-and more data than researchers know what to do with"},{"title3":"Metabolomics enables precision medicine:&quot;a white paper, community perspective&quot;"},{"title3":"MetaboAnalyst 40: towards more transparent and integrative metabolomics analysis"},{"title3":"XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification"},{"title3":"MS-DIAL: data-independent MS/MS deconvolution for comprehensive metabolome analysis"},{"title3":"Metabolomics: a primer"},{"title3":"Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy"},{"title3":"Serum metabolome analysis by 1 H-NMR reveals differences between chronic lymphocytic leukaemia molecular subgroups"},{"title3":"Comprehensive metabolomic characterization of coronary artery diseases"},{"title3":"Pharmaco-metabonomic phenotyping and personalized drug treatment"},{"title3":"Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism"},{"title3":"Pharmacometabonomics and personalized medicine"},{"title3":"Metabolomics applications in precision medicine: An oncological perspective"},{"title3":"BTS guidelines for the management of community acquired pneumonia in childhood"},{"title3":"Community-acquired pneumonia in children"},{"title3":"Incidence and characteristics of viral community-acquired pneumonia in adults"},{"title3":"Etiology of community-acquired pneumonia: increased microbiological yield with new diagnostic methods"},{"title3":"Respiratory viruses in adults with community-acquired pneumonia"},{"title3":"British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011"},{"title3":"Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults"},{"title3":"Respiratory syncytial virus: current progress in vaccine development"},{"title3":"Pharmacologic advances in the treatment and prevention of respiratory syncytial virus"},{"title3":"Pharmacotherapy of respiratory syncytial virus infection"},{"title3":"Potential role of metabolomics apporoaches in the area of traditional Chinese medicine: as pillars of the bridge between Chinese and Western medicine"},{"title3":"The application of metabolomics in traditional Chinese medicine opens up a dialogue between Chinese and Western medicine"},{"title3":"Metabolomics: towards understanding traditional Chinese medicine"},{"title3":"Metabolomics characterization and identification of a rat model of myocardial ischemia with blood stasis syndrome and qi-yin deficiency syndrome"},{"title3":"Urine metabolomics analysis for biomarker discovery and detection of jaundice syndrome in patients with liver disease"},{"title3":"Metabolic urinary profiling of alcohol hepatotoxicity and intervention effects of Yin Chen Hao Tang in rats using ultra-performance liquid chromatography/electrospray ionization quadruple time-of-flight mass spectrometry"},{"title3":"Evidence-based patient classification for Traditional Chinese Medicine"},{"title3":"Liangyue D, Yijun G, Shuhui H, Xiaoping J, Yang L, Rufen W. Chinese acupuncture and moxibustion. Trad Med Asia. 2001, 75."},{"title3":"Metabolomics Workbench: an international repository for metabolomics data and metadata, metabolite standards, protocols, tutorials and training, and analysis tools"},{"title3":"Traditional Chinese herbal medicine as a source of molecules with antiviral activity"},{"title3":"Respiratory syncytial virus and rhinovirus bronchiolitis are associated with distinct metabolic pathways"},{"title3":"Metabolomics investigation reveals metabolite mediators associated with acute lung injury and repair in a murine model of influenza pneumonia"},{"title3":"Gas chromatography-mass spectrometry based plasma metabolomics of H1N1-induced inflammation in mice and intervention with Flos Lonicerae Japonica-Fructus Forsythiae herb pair"},{"title3":"Modified Jiu Wei Qiang Huo decoction improves dysfunctional metabolomics in influenza A pneumonia-infected mice"},{"title3":"Mechanism analysis of mice model with H1N1 influenza virus intervened by Mahuang Xixin fuzi tang based on fecal metabolomics"},{"title3":"Metabolomics on Pudilan Xiaoyan Oral Liquid in treatment of Influenza A/H1N1-induced pneumonia based on GC-MS"}]},{"title2":"The science and art of pediatric critical care nutrition","References":[]},{"title2":"[Communication, information, and roles of parents in the pediatric intensive care unit: a review article]","References":[]},{"title2":"Nurses' reflections on benefits and challenges of implementing family-centered care in pediatric intensive care units","References":[{"title3":"Traumatic stress in parents of children admitted to the pediatric intensive care unit"},{"title3":"Preventing posttraumatic stress following pediatric injury: a randomized controlled trial of a web-based psycho-educational intervention for parents"},{"title3":"Parental coping and bereavement outcome after the death of a child in the pediatric intensive care unit"},{"title3":"Family response to critical illness: postintensive care syndrome-family"},{"title3":"The impact on parents of a child's admission to intensive care: integration of qualitative findings from a cross-sectional study"},{"title3":"Predictors of stress among parents in pediatric intensive care unit: a prospective observational study"},{"title3":"Loss of parental role as a cause of stress in the neonatal intensive care unit"},{"title3":"Family-centered care in the pediatric intensive care unit"},{"title3":"Family-centred care: a concept analysis"},{"title3":"A concept analysis of family-centered care in the NICU"},{"title3":"Coping with the neonatal intensive care unit experience: parents' strategies and views of staff support"},{"title3":"Families and health-care professionals' perspectives and expectations of family-centred care: hidden expectations and unclear roles"},{"title3":"Family-centred care of children in hospital: a concept analysis"},{"title3":"Family-centered care in neonatal intensive care unit: a concept analysis"},{"title3":"An experimental evaluation of a model child life program"},{"title3":"Family-centered pediatric nursing care: state of the science"},{"title3":"Building trust through communication in the intensive care unit: HICCC"},{"title3":"What's in a name? Qualitative description revisited"},{"title3":"Characteristics of qualitative descriptive studies: a systematic review"},{"title3":"The Family Communication Study: a randomized trial of prospective palliative care consultation, study methodology and perceptions of participation burden"},{"title3":"How many interviews are enough? An experiment with data saturation and variability"},{"title3":"Choose your method: a comparison of phenomenology, discourse analysis, and grounded theory"},{"title3":"Three approaches to qualitative content analysis"},{"title3":"Involving parents in managing their child's long-term condition:a concept synthesis of family-centered care and partnership-in-care"},{"title3":"Palliative care in the pediatric ICU: challenges and opportunities for family-centered practice"}]}]},{"title1":"Clinical characteristics of a case series of children with coronavirus disease 2019","References":[{"title2":"Coronavirus infections-more than just the common cold","References":[]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Novel coronavirus infection in hospitalized infants under 1 year of age in China","References":[]}]},{"title1":"High-Resolution Computed Tomography Manifestations of 5 Pediatric Patients With 2019 Novel Coronavirus","References":[{"title2":"Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China","References":[{"title3":"Wang C, Horby PW, Hayden FG, Gao GF (2020) A novel coronavirus outbreak of global health concern. Lancet. S0140-6736(20)30185-30189"},{"title3":"Emerging coronaviruses: Genome structure, replication, and pathogenesis"},{"title3":"Chan JF, Yuan S, Kok KH et al (2020) A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet S0140-6736(20)30154-30159"},{"title3":"Huang C, Wang Y, Li X et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet S0140-6736(20)30183-30185"},{"title3":"Tan W, Zhao X, Ma X et al (2020) A novel coronavirus genome identified in a cluster of pneumonia cases- Wuhan, China 2019-2020. China CDC Weekly 2:61-62. Available via http://weekly.chinacdc.cn/en/article/id/a3907201-f64f-4154-a19e-4253b453d10c"}]},{"title2":"CT imaging features of 2019 novel coronavirus (2019-nCoV)","References":[{"title3":"Novel Coronavirus - China. World Health Organization"},{"title3":"Novel Coronavirus (2019-nCoV). World Health Organization"},{"title3":"Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. World Health Organization"},{"title3":"Middle East respiratory syndrome Coronavirus (MERS-CoV). World Health Organization"},{"title3":"Situation report - 8. World Health Organization"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Fleischner Society: glossary of terms for thoracic imaging"},{"title3":"Radiographic and CT Features of Viral Pneumonia"},{"title3":"Severe acute respiratory syndrome: temporal lung changes at thin-section CT in 30 patients"},{"title3":"Severe acute respiratory syndrome: radiographic appearances and pattern of progression in 138 patients"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) infection: chest CT findings"},{"title3":"Middle East respiratory syndrome-Coronavirus infection: a case report of serial computed tomographic findings in a young male patient"},{"title3":"About 2019 Novel Coronavirus (2019-nCoV). Centers for Disease Control and Prevention"},{"title3":"Radiologic pattern of disease in patients with severe acute respiratory syndrome: the Toronto experience"}]},{"title2":"Emerging coronavirus 2019-nCoV pneumonia","References":[]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia","References":[]}]},{"title1":"Chest CT imaging characteristics of COVID-19 pneumonia in preschool children: a retrospective study","References":[{"title2":"World Health Organization: Coronavirus disease (COVID-19) outbreak. 2020, (https://www.who.int).","References":[]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"Chung M, Bernheim A, Mei X, Zhang N, Huang M, Zeng X, Cui J, Xu W, Yang Y, Fayad ZA. CT imaging features of 2019 novel coronavirus (2019-nCoV). Radiology. 2020. 10.1148/radiol.2020200230.","References":[]},{"title2":"Lei J, Li J, Li X, Qi X. CT imaging of the 2019 novel coronavirus (2019-nCoV) pneumonia. Radiology. 2020. 10.1148/radiol.2020200236.","References":[]},{"title2":"Li Y, Xia L. Coronavirus Disease 2019 (COVID-19): role of chest CT in diagnosis and management. Am J Roentgenol. 2020(4):1-7.","References":[]},{"title2":"Zhou S, Wang Y, Zhu T, Xia L. CT Features of Coronavirus Disease 2019 (COVID-19) pneumonia in 62 patients in Wuhan, China. Am Jo Roentgenol. 2020(5):1-8.","References":[]},{"title2":"Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei C, Hui DS. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020. 10.1056/NEJMoa2002032.","References":[]},{"title2":"Chest CT findings in 2019 novel coronavirus (2019-nCoV) infections from Wuhan, China: key points for the radiologist","References":[{"title3":"A Novel Coronavirus from Patients with Pneumonia in China"},{"title3":"Geneva, Switzerland: World Health Organization"},{"title3":"Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia"},{"title3":"CT imaging features of 2019 novel coronavirus (2019-nCoV)"},{"title3":"High-resolution CT findings of severe acute respiratory syndrome at presentation and after admission"},{"title3":"SARS: imaging of severe acute respiratory syndrome"},{"title3":"Severe acute respiratory syndrome: temporal lung changes at thin-section CT in 30 patients"},{"title3":"Acute Middle East Respiratory Syndrome Coronavirus: Temporal Lung Changes Observed on the Chest Radiographs of 55 Patients"},{"title3":"CT correlation with outcomes in 15 patients with acute Middle East respiratory syndrome coronavirus"},{"title3":"Acute respiratory distress syndrome: CT abnormalities at long-term follow-up"},{"title3":"Acute respiratory distress syndrome: imaging of the injured lung"}]},{"title2":"Kim H. Outbreak of novel coronavirus (COVID-19): what is the role of radiologists? Eur Radiol. 2020. 10.1007/s00330-020-06748-2.","References":[]},{"title2":"Pneumonia associated with 2019 novel coronavirus: can computed tomographic findings help predict the prognosis of the disease?","References":[{"title3":"Novel coronavirus pneumonia outbreak in 2019: computed tomographic findings in two cases"},{"title3":"CT imaging features of 2019 Novel Coronavirus (2019-nCoV)"},{"title3":"Viral pneumonias in adults: radiologic and pathologic finidings"},{"title3":"Thin-section CT of severe acute respiratory syndrome: evaluation of 73 patients exposed to or with the disease"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) infection: chest CT findings"},{"title3":"Middle East respiratory syndrome-coronavirus infection: a case report of serial computed tomographic findings in a young male patient"},{"title3":"Infectious pneumonia in immunocompetent patients: updates in clinical and imaging features"},{"title3":"Computed tomography findings of influenza A (H1N1) pneumonia in adults: pattern analysis and prognostic comparisons"},{"title3":"CT correlation with outcomes in 15 patients with acute Middle East respiratory syndrome coronavirus"}]},{"title2":"National Health Commission of the People's Republic of China: Diagnosis and Treatment Protocols of Coronavirus Disease 2019 (6th Trial Edition). 2020, http://www.nhc.gov.cn.","References":[]},{"title2":"Liu KC, Xu P, Lv WF, Qiu XH, Yao JL, Gu JF. CT manifestations of coronavirus disease-2019: a retrospective analysis of 73 cases by disease severity. Eur J Radiol. 2020. 10.1016/j.ejrad.2020.108941.","References":[]},{"title2":"Du Z, Wang L, Cauchemez S, Xu X, Wang X, Cowling BJ, Meyers LA: Risk of 2019 novel coronavirus importations throughout China prior to the Wuhan quarantine. medRxiv 2020, doi: 10.1101/2020.01.28.20019299v1.","References":[]},{"title2":"Lu Q, Shi Y. Coronavirus disease (COVID-19) and neonate: what neonatologist need to know. J Med Virol. 2020. 10.1002/jmv.25740.","References":[]},{"title2":"Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith H, Azman AS, Reich NG, Lessler J. The incubation period of 2019-nCoV from publicly reported confirmed cases: estimation and application. Ann Intern Med. 2020. 10.7326/M20-0504.","References":[]},{"title2":"Liu W, Zhang Q, Chen J, Xiang R, Song H, Shu S, Chen L, Liang L, Zhou J, You L. Detection of Covid-19 in children in early January 2020 in Wuhan, China. N Engl J Med. 2020. 10.1056/NEJMc2003717.","References":[]},{"title2":"Bernheim A, Mei X, Huang M, Yang Y, Fayad ZA, Zhang N, Diao K, Lin B, Zhu X, Li K. Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection. Radiology. 2020. 10.1148/radiol.2020200463.","References":[]},{"title2":"Dai WC, Zhang HW, Yu J, Xu HJ, Chen H, Luo S-P, Zhang H, Liang LH, Wu XL, Lei Y. CT imaging and differential diagnosis of COVID-19. Can Assoc Radiol J. 2020. 10.1177/0846537120913033.","References":[]},{"title2":"Zu ZY, Jiang MD, Xu PP, Chen W, Ni QQ, Lu GM, Zhang LJ. Coronavirus disease 2019 (COVID-19): a perspective from China. Radiology. 2020. 10.1148/radiol.2020200490.","References":[]},{"title2":"Mycoplasma pneumonia: clinical and radiographic features in 39 children","References":[]},{"title2":"Severe community-acquired pneumonia caused by human adenovirus in immunocompetent adults: a multicenter case series","References":[{"title3":"Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults"},{"title3":"Emergence of community-acquired adenovirus type 55 as a cause of community-onset pneumonia"},{"title3":"Adenovirus"},{"title3":"Severe community-acquired adenovirus pneumonia in an immunocompetent 44-year-old woman: a case report and review of the literature"},{"title3":"A community-based outbreak of severe respiratory illness caused by human adenovirus serotype 14"},{"title3":"New adenovirus species found in a patient presenting with gastroenteritis"},{"title3":"Respiratory disease caused by a species B2 adenovirus in a military camp in Turkey"},{"title3":"Outbreak of febrile respiratory illness associated with adenovirus 11a infection in a Singapore military training cAMP"},{"title3":"Outcomes of early administration of cidofovir in non-immunocompromised patients with severe adenovirus pneumonia"},{"title3":"Outbreak of acute respiratory disease in China caused by B2 species of adenovirus type 11"},{"title3":"Epidemiology of human adenovirus and molecular characterization of human adenovirus 55 in China, 2009-2012"},{"title3":"Prevalence of adenovirus in children with acute respiratory tract infection in Lanzhou, China"},{"title3":"Severe community-acquired pneumonia. Assessment of severity criteria"},{"title3":"A prediction rule to identify low-risk patients with community-acquired pneumonia"},{"title3":"Detection of three human adenovirus species in adults with acute respiratory infection in China"},{"title3":"Viral etiology of community-acquired pneumonia among adolescents and adults with mild or moderate severity and its relation to age and severity"},{"title3":"Severe community-acquired pneumonia caused by adenovirus type 11 in immunocompetent adults in Beijing"},{"title3":"Emergent severe acute respiratory distress syndrome caused by adenovirus type 55 in immunocompetent adults in 2013: a prospective observational study"},{"title3":"Fatal pneumonia cases caused by human adenovirus 55 in immunocompetent adults"},{"title3":"The prognostic significance of respiratory rate in patients with pneumonia: a retrospective analysis of data from 705,928 hospitalized patients in Germany from 2010-2012"},{"title3":"Low C-reactive protein values at admission predict mortality in patients with severe community-acquired pneumonia caused by Streptococcus pneumoniae that require intensive care management"},{"title3":"C-reactive protein as a prognostic factor for mortality in pneumonia patients with liver cirrhosis"},{"title3":"Corticosteroids in the treatment of community-acquired pneumonia in adults: a meta-analysis"},{"title3":"Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia: A Systematic Review and Meta-analysis"},{"title3":"Efficacy and Safety of Corticosteroids for Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis"},{"title3":"Dexamethasone in children mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus: a randomized controlled trial"},{"title3":"Early corticosteroids in severe influenza A/H1N1 pneumonia and acute respiratory distress syndrome"},{"title3":"Efficacy of oral ribavirin in hematologic disease patients with paramyxovirus infection: analytic strategy using propensity scores"},{"title3":"Pulse methylprednisolone therapy in type 3 adenovirus pneumonia with hypercytokinemia"}]},{"title2":"Swine-origin influenza a (H1N1) viral infection: radiographic and CT findings","References":[]},{"title2":"High-resolution CT findings in a patient with influenza a (H1N1) virus-associated pneumonia","References":[]}]},{"title1":"Clinical characteristics and radiological features of children infected with the 2019 novel coronavirus","References":[{"title2":"A novel coronavirus from patients with pneumonia in China, 2019","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Inferring the hosts of coronavirus using dual statistical models based on nucleotide composition"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"2019 novel coronavirus (2019-nCoV) outbreak: a new challenge"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan"},{"title3":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China"},{"title3":"Novel Wuhan (2019-nCoV) coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus phylogeny: toward consensus"},{"title3":"Diagnosis and treatment of new coronavirus pneumonia (trial version 7) [J / OL]. Tianjin J Tradit Chin Med. 2020;1-5. http://kns.cnki.net/kcms/detail/12.1349.R.20200304.1638.006.html. Accessed 3 June 2020."},{"title3":"Clinical outcome of standardized oxygen therapy nursing strategy in COVID-19"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus"},{"title3":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection"},{"title3":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV"},{"title3":"Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients"},{"title3":"Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study"},{"title3":"C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early"},{"title3":"Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Human ipsc-derived cardiomyocytes are susceptible to Sars-Cov-2 infection"},{"title3":"Cardiovascular complications in COVID-19"},{"title3":"COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"}]},{"title2":"Novel coronavirus (2019-nCoV). Situation reports-19","References":[]},{"title2":"CT imaging features of 2019 novel coronavirus (2019-nCoV)","References":[{"title3":"Novel Coronavirus - China. World Health Organization"},{"title3":"Novel Coronavirus (2019-nCoV). World Health Organization"},{"title3":"Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. World Health Organization"},{"title3":"Middle East respiratory syndrome Coronavirus (MERS-CoV). World Health Organization"},{"title3":"Situation report - 8. World Health Organization"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Fleischner Society: glossary of terms for thoracic imaging"},{"title3":"Radiographic and CT Features of Viral Pneumonia"},{"title3":"Severe acute respiratory syndrome: temporal lung changes at thin-section CT in 30 patients"},{"title3":"Severe acute respiratory syndrome: radiographic appearances and pattern of progression in 138 patients"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) infection: chest CT findings"},{"title3":"Middle East respiratory syndrome-Coronavirus infection: a case report of serial computed tomographic findings in a young male patient"},{"title3":"About 2019 Novel Coronavirus (2019-nCoV). Centers for Disease Control and Prevention"},{"title3":"Radiologic pattern of disease in patients with severe acute respiratory syndrome: the Toronto experience"}]},{"title2":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","References":[{"title3":"The 2019-nCoV Outbreak Joint Field Epidemiology Investigation Team, Li Q. Notes from the field: an outbreak of NCIP (2019-nCoV) infection in China : Wuhan, Hubei Province, 2019-2020."},{"title3":"A novel coronavirus genome identified in a cluster of pneumonia cases : Wuhan, China 2019-2020."},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Use of national pneumonia surveillance to describe influenza A(H7N9) virus epidemiology, China, 2004-2013."},{"title3":"A novel coronavirus emerging in China : key questions for impact assessment."},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus."},{"title3":"Transmission dynamics and control of severe acute respiratory syndrome."},{"title3":"Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future."},{"title3":"Coronavirus infections : more than just the common cold."},{"title3":"Another decade, another coronavirus."},{"title3":"SARS and MERS: recent insights into emerging coronaviruses."},{"title3":"MERS, SARS, and Ebola: the role of super-spreaders in infectious disease."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at January 2020."},{"title3":"How to maintain surveillance for novel influenza A H1N1 when there are too many cases to count."}]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"Emerging coronavirus 2019-nCoV pneumonia","References":[]},{"title2":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","References":[]},{"title2":"From SARS to MERS, thrusting coronaviruses into the spotlight","References":[{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome"},{"title3":"Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor"},{"title3":"A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"SARS and MERS: Recent insights into emerging coronaviruses"},{"title3":"WHO Guidelines for the Global Surveillance of Severe Acute Respiratory Syndrome (SARS)"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"High Prevalence of MERS-CoV Infection in Camel Workers in Saudi Arabia"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: A descriptive study"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: A serologic, epidemiologic, and clinical description"},{"title3":"Response to Emergence of Middle East Respiratory Syndrome Coronavirus, Abu Dhabi, United Arab Emirates, 2013-2014"},{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus"},{"title3":"An observational, laboratory-based study of outbreaks of middle East respiratory syndrome coronavirus in Jeddah and Riyadh, kingdom of Saudi Arabia, 2014"},{"title3":"Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015"},{"title3":"Severe acute respiratory syndrome (SARS): A year in review"},{"title3":"Coronaviruses: An overview of their replication and pathogenesis"},{"title3":"Current understanding of middle east respiratory syndrome coronavirus infection in human and animal models"},{"title3":"MERS-CoV spike protein: A key target for antivirals"},{"title3":"The spike protein of SARS-CoV:A target for vaccine and therapeutic development"},{"title3":"Middle East respiratory syndrome"},{"title3":"CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus"},{"title3":"Epithelial Cells Lining Salivary Gland Ducts Are Early Target Cells of Severe Acute Respiratory Syndrome Coronavirus Infection in the Upper Respiratory Tracts of Rhesus Macaques"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"The life cycle of SARS coronavirus in Vero E6 cells"},{"title3":"Pathogenetic mechanisms of severe acute respiratory syndrome"},{"title3":"Pathology and pathogenesis of severe acute respiratory syndrome"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: Implications for pathogenesis and virus transmission pathways"},{"title3":"Dipeptidyl Peptidase 4 Distribution in the Human Respiratory Tract: Implications for the Middle East Respiratory Syndrome"},{"title3":"Differential Expression of the Middle East Respiratory Syndrome Coronavirus Receptor in the Upper Respiratory Tracts of Humans and Dromedary Camels"},{"title3":"2014 MERS-CoV outbreak in Jeddah:A link to health care facilities"},{"title3":"Acute renal impairment in coronavirus-associated severe acute respiratory syndrome"},{"title3":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: A single-center experience in Saudi Arabia"},{"title3":"Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia"},{"title3":"Dipeptidyl-peptidase IV from bench to bedside: An update on structural properties, functions, and clinical aspects of the enzyme DPP IV"},{"title3":"Productive replication of Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response"},{"title3":"Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: Implications for pathogenesis"},{"title3":"Middle East Respiratory Syndrome Coronavirus Efficiently Infects Human Primary T Lymphocytes and Activates the Extrinsic and Intrinsic Apoptosis Pathways"},{"title3":"MERS coronavirus induces apoptosis in kidney and lung by upregulating Smad7 and FGF2"},{"title3":"Protective T Cell Res.ponses Featured by Concordant Recognition of Middle East Respiratory Syndrome Coronavirus-Derived CD8+ T Cell Epitopes and Host MHC"},{"title3":"Tropism of and innate immune responses to the novel human betacoronavirus lineage C virus in human ex vivo respiratory organ cultures"},{"title3":"Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: Implications for pathogenesis and treatment"},{"title3":"The Genome sequence of the SARS-associated coronavirus"},{"title3":"Identification of two critical amino acid residues of the severe acute respiratory syndrome coronavirus spike protein for its variation in zoonotic tropism transition via a double substitution strategy"},{"title3":"Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"Receptor recognition mechanisms of coronaviruses: A decade of structural studies"},{"title3":"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26"},{"title3":"Structure of the fusion core and inhibition of fusion by a heptad repeat peptide derived from the S protein of Middle East respiratory syndrome coronavirus"},{"title3":"Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4"},{"title3":"Current advancements and potential strategies in the development of MERS-CoV vaccines"},{"title3":"Identification of a receptor-binding domain in the S protein of the novel human coronavirus Middle East respiratory syndrome coronavirus as an essential target for vaccine development"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Crystal structure of the receptor-binding domain from newly emerged Middle East respiratory syndrome coronavirus"},{"title3":"Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor"},{"title3":"Core structure of S2 from the human coronavirus NL63 spike glycoprotein"},{"title3":"Crystal structure of severe acute respiratory syndrome coronavirus spike protein fusion core"},{"title3":"Structural basis for coronavirus-mediated membrane fusion. Crystal structure of mouse hepatitis virus spike protein fusion core"},{"title3":"S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients"},{"title3":"SARS-associated coronavirus"},{"title3":"Conformational states of the severe acute respiratory syndrome coronavirus spike protein ectodomain"},{"title3":"A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2"},{"title3":"The SARS-CoV S glycoprotein: Expression and functional characterization"},{"title3":"A molecular docking model of SARS-CoV S1 protein in complex with its receptor, human ACE2"},{"title3":"A single amino acid substitution (R441A) in the receptor-binding domain of SARS coronavirus spike protein disrupts the antigenic structure and binding activity"},{"title3":"Identification and characterization of the putative fusion peptide of the severe acute respiratory syndrome-associated coronavirus spike protein"},{"title3":"pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN"},{"title3":"Specific asparagine-linked glycosylation sites are critical for DC-SIGN- and L-SIGN-mediated severe acute respiratory syndrome coronavirus entry"},{"title3":"A decade after SARS: Strategies for controlling emerging coronaviruses"},{"title3":"Amino acids 1055 to 1192 in the S2 region of severe acute respiratory syndrome coronavirus S protein induce neutralizing antibodies: Implications for the development of vaccines and antiviral agents"},{"title3":"An exposed domain in the severe acute respiratory syndrome coronavirus spike protein induces neutralizing antibodies"},{"title3":"Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS"},{"title3":"A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice"},{"title3":"Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcgammaRII-dependent entry into B cells in vitro"},{"title3":"Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets"},{"title3":"Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets"},{"title3":"Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants"},{"title3":"Evaluation of candidate vaccine approaches for MERS-CoV"},{"title3":"Rapid development of vaccines against emerging pathogens: The replication-deficient simian adenovirus platform technology"},{"title3":"Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB/c mice"},{"title3":"DNA vaccine encoding Middle East respiratory syndrome coronavirus S1 protein induces protective immune responses in mice"},{"title3":"Immunogenicity of Candidate MERS-CoV DNA Vaccines Based on the Spike Protein"},{"title3":"MERS-CoV vaccine candidates in development: The current landscape"},{"title3":"Airway Memory CD4+ T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses"},{"title3":"SARS vaccines: Where are we?"},{"title3":"Safety and immunogenicity from a phase I trial of inactivated severe acute respiratory syndrome coronavirus vaccine"},{"title3":"Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus"},{"title3":"Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus"},{"title3":"Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease"},{"title3":"A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge"},{"title3":"Effects of respiratory syncytial virus infection and major basic protein derived from eosinophils in pulmonary alveolar epithelial cells (A549)"},{"title3":"Complete protection against severe acute respiratory syndrome coronavirus-mediated lethal respiratory disease in aged mice by immunization with a mouse-adapted virus lacking E protein"},{"title3":"A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease"},{"title3":"Engineering a replication-competent, propagation-defective Middle East respiratory syndrome coronavirus as a vaccine candidate"},{"title3":"Engineering attenuated virus vaccines by controlling replication fidelity"},{"title3":"Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters"},{"title3":"Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants"},{"title3":"Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region"},{"title3":"Recombinant Receptor Binding Domain Protein Induces Partial Protective Immunity in Rhesus Macaques Against Middle East Respiratory Syndrome Coronavirus Challenge"},{"title3":"The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection"},{"title3":"Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein"},{"title3":"SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus"},{"title3":"The expression of membrane protein augments the specific responses induced by SARS-CoV nucleocapsid DNA immunization"},{"title3":"SARS coronavirus nucleocapsid immunodominant T-cell epitope cluster is common to both exogenous recombinant and endogenous DNA-encoded immunogens"},{"title3":"Procyanidins and butanol extract of Cinnamomi Cortex inhibit SARS-CoV infection"},{"title3":"Screening and identification of linear B-cell epitopes and entry-blocking peptide of severe acute respiratory syndrome (SARS)-associated coronavirus using synthetic overlapping peptide library"},{"title3":"Synthetic peptides outside the spike protein heptad repeat regions as potent inhibitors of SARS-associated coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides"},{"title3":"Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein"},{"title3":"Amino acid substitutions in the S2 subunit of mouse hepatitis virus variant V51 encode determinants of host range expansion"},{"title3":"Antigenic and immunogenic characterization of recombinant baculovirus-expressed severe acute respiratory syndrome coronavirus spike protein: Implication for vaccine design"},{"title3":"Cross-neutralization of human and palm civet severe acute respiratory syndrome coronaviruses by antibodies targeting the receptor-binding domain of spike protein"},{"title3":"Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: Importance for designing SARS vaccines"},{"title3":"Characterization of neutralizing monoclonal antibodies recognizing a 15-residues epitope on the spike protein HR2 region of severe acute respiratory syndrome coronavirus (SARS-CoV)"},{"title3":"Neutralizing antibodies in patients with severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"An efficient method to make human monoclonal antibodies from memory B cells: Potent neutralization of SARS coronavirus"},{"title3":"Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challenge"},{"title3":"Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies"},{"title3":"Generation and characterization of human monoclonal neutralizing antibodies with distinct binding and sequence features against SARS coronavirus using XenoMouse"},{"title3":"Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus"},{"title3":"Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association"},{"title3":"Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: Implications for virus fusogenic mechanism and identification of fusion inhibitors"},{"title3":"Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus"},{"title3":"A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein"},{"title3":"A conformation-dependent neutralizing monoclonal antibody specifically targeting receptor-binding domain in Middle East respiratory syndrome coronavirus spike protein"},{"title3":"Adenosine deaminase acts as a natural antagonist for dipeptidyl peptidase 4-mediated entry of the Middle East respiratory syndrome coronavirus"},{"title3":"Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)"},{"title3":"The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies"},{"title3":"Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2"},{"title3":"Protease inhibitors targeting coronavirus and filovirus entry"},{"title3":"Therapeutic Options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV)-possible lessons from a systematic review of SARS-CoV therapy"},{"title3":"Interferon-beta and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays"},{"title3":"Human monoclonal antibody combination against SARS coronavirus: Synergy and coverage of escape mutants"},{"title3":"A serological survey on neutralizing antibody titer of SARS convalescent sera"},{"title3":"Fully Human Monoclonal Antibody Directed to Proteolytic Cleavage Site in Severe Acute Respiratory Syndrome (SARS) Coronavirus S Protein Neutralizes the Virus in a Rhesus Macaque SARS Model"},{"title3":"Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non-human Primates"},{"title3":"Human Neutralizing Monoclonal Antibody Inhibition of Middle East Respiratory Syndrome Coronavirus Replication in the Common Marmoset"},{"title3":"SARS: Systematic Review of Treatment Effects"},{"title3":"SARS: Clinical presentation, transmission, pathogenesis and treatment options"},{"title3":"Treatment with Lopinavir/Ritonavir or Interferon-beta1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset"},{"title3":"Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice"},{"title3":"Mice susceptible to SARS coronavirus"},{"title3":"Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice"},{"title3":"Mice transgenic for human angiotensin-converting enzyme 2 provide a model for SARS coronavirus infection"},{"title3":"Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans"},{"title3":"Resolution of primary severe acute respiratory syndrome-associated coronavirus infection requires Stat1"},{"title3":"Molecular determinants of severe acute respiratory syndrome coronavirus pathogenesis and virulence in young and aged mouse models of human disease"},{"title3":"Age-related increases in PGD(2) expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice"},{"title3":"T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice"},{"title3":"Evasion by stealth: Inefficient immune activation underlies poor T cell response and severe disease in SARS-CoV-infected mice"},{"title3":"MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV"},{"title3":"T cell responses to whole SARS coronavirus in humans"},{"title3":"Antibody response and viraemia during the course of severe acute respiratory syndrome (SARS)-associated coronavirus infection"},{"title3":"A double-inactivated whole virus candidate SARS coronavirus vaccine stimulates neutralising and protective antibody responses"},{"title3":"Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice"},{"title3":"Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine"},{"title3":"SARS vaccine protective in mice"},{"title3":"Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice"},{"title3":"An immunosuppressed Syrian golden hamster model for SARS-CoV infection"},{"title3":"Protection from infection with severe acute respiratory syndrome coronavirus in a Chinese hamster model by equine neutralizing F(ab')2"},{"title3":"Is there an ideal animal model for SARS?"},{"title3":"Therapy with a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody reduces disease severity and viral burden in golden Syrian hamsters"},{"title3":"Virology: SARS virus infection of cats and ferrets"},{"title3":"Pathology of experimental SARS coronavirus infection in cats and ferrets"},{"title3":"Severe acute respiratory syndrome coronavirus infection in vaccinated ferrets"},{"title3":"Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets"},{"title3":"Severe acute respiratory syndrome vaccine efficacy in ferrets: Whole killed virus and adenovirus-vectored vaccines"},{"title3":"An animal model of SARS produced by infection of Macaca mulatta with SARS coronavirus"},{"title3":"Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys"},{"title3":"Macaque model for severe acute respiratory syndrome"},{"title3":"Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque"},{"title3":"Spatiotemporal interplay of severe acute respiratory syndrome coronavirus and respiratory mucosal cells drives viral dissemination in rhesus macaques"},{"title3":"Aetiology: Koch's postulates fulfilled for SARS virus"},{"title3":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome"},{"title3":"Pneumonitis and multi-organ system disease in common marmosets (Callithrix jacchus) infected with the severe acute respiratory syndrome-associated coronavirus"},{"title3":"Cynomolgus macaque as an animal model for severe acute respiratory syndrome"},{"title3":"Animal models for SARS"},{"title3":"Rhesus angiotensin converting enzyme 2 supports entry of severe acute respiratory syndrome coronavirus in Chinese macaques"},{"title3":"Mouse dipeptidyl peptidase 4 is not a functional receptor for Middle East respiratory syndrome coronavirus infection"},{"title3":"Wild-type and innate immune-deficient mice are not susceptible to the Middle East respiratory syndrome coronavirus"},{"title3":"Domestic Pig Unlikely Reservoir for MERS-CoV"},{"title3":"Permissivity of Dipeptidyl Peptidase 4 Orthologs to Middle East Respiratory Syndrome Coronavirus Is Governed by Glycosylation and Other Complex Determinants"},{"title3":"Asymptomatic Middle East respiratory syndrome coronavirus infection in rabbits"},{"title3":"The Middle East respiratory syndrome coronavirus (MERS-CoV) does not replicate in Syrian hamsters"},{"title3":"Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin mice"},{"title3":"Multi-Organ Damage in Human Dipeptidyl Peptidase 4 Transgenic Mice Infected with Middle East Respiratory Syndrome-Coronavirus"},{"title3":"Rapid generation of a mouse model for Middle East respiratory syndrome"},{"title3":"Severe acute respiratory syndrome coronavirus infection of mice transgenic for the human Angiotensin-converting enzyme 2 virus receptor"},{"title3":"A mouse model for MERS coronavirus-induced acute respiratory distress syndrome"},{"title3":"An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels"},{"title3":"Infection, Replication, and Transmission of Middle East Respiratory Syndrome Coronavirus in Alpacas"},{"title3":"Experimental Infection and Response to Rechallenge of Alpacas with Middle East Respiratory Syndrome Coronavirus"},{"title3":"An Animal Model of MERS Produced by Infection of Rhesus Macaques with MERS Coronavirus"},{"title3":"Comparative pathology of rhesus macaque and common marmoset animal models with Middle East respiratory syndrome coronavirus"},{"title3":"Infection with MERS-CoV causes lethal pneumonia in the common marmoset"},{"title3":"Pneumonia from human coronavirus in a macaque model"},{"title3":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques"},{"title3":"Intratracheal exposure of common marmosets to MERS-CoV Jordan-n3/2012 or MERS-CoV EMC/2012 isolates does not result in lethal disease"},{"title3":"Efficient replication of severe acute respiratory syndrome coronavirus in mouse cells is limited by murine angiotensin-converting enzyme 2"},{"title3":"Civets are equally susceptible to experimental infection by two different severe acute respiratory syndrome coronavirus isolates"},{"title3":"Receptor variation and susceptibility to Middle East respiratory syndrome coronavirus infection"},{"title3":"Host species restriction of Middle East respiratory syndrome coronavirus through its receptor, dipeptidyl peptidase 4"}]},{"title2":"MERS, SARS and other coronaviruses as causes of pneumonia","References":[{"title3":"Coronavirus pathogenesis"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"  . Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fact Sheet [Accessed 28 Aug 2017.] Available from URL: http://www.who.int/mediacentre/factsheets/mers-cov/en/."},{"title3":"Discovery of seven novel Mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus"},{"title3":"Evidence supporting a zoonotic origin of human coronavirus strain NL63"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Close relative of human Middle East respiratory syndrome coronavirus in bat, South Africa"},{"title3":"Molecular diversity of coronaviruses in bats"},{"title3":"Discovery of a novel coronavirus, China Rattus coronavirus HKU24, from Norway rats supports the murine origin of Betacoronavirus 1 and has implications for the ancestor of Betacoronavirus lineage A"},{"title3":"Transmission of Middle East respiratory syndrome coronavirus infections in healthcare settings, Abu Dhabi"},{"title3":"Middle East Respiratory syndrome coronavirus outbreak in the Republic of Korea, 2015"},{"title3":"Epidemiology, transmission dynamics and control of SARS: the 2002-2003 epidemic"},{"title3":"Clinical and epidemiologic characteristics of spreaders of Middle East respiratory syndrome coronavirus during the 2015 Outbreak in Korea"},{"title3":"Infectivity of an asymptomatic patient with Middle East respiratory syndrome coronavirus infection"},{"title3":"Clinical features and molecular epidemiology of coronavirus-HKU1-associated community-acquired pneumonia"},{"title3":"Severe acute respiratory syndrome (SARS): a year in review"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"Risk Factors for Primary Middle East Respiratory Syndrome Coronavirus Illness in Humans, Saudi Arabia, 2014"},{"title3":"Outbreaks of Middle East respiratory syndrome in two hospitals initiated by a single patient in Daejeon, South Korea"},{"title3":"First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013"},{"title3":"Coronavirus HKU1 and other coronavirus infections in Hong Kong"},{"title3":"Epidemiology of coronavirus-associated respiratory tract infections and the role of rapid diagnostic tests: a prospective study"},{"title3":"Prevalence and molecular epidemiology of human coronavirus HKU1 in patients with acute respiratory illness"},{"title3":"Viral infection in adults hospitalized with community-acquired pneumonia: prevalence, pathogens, and presentation"},{"title3":"Community-acquired pneumonia requiring hospitalization among U.S. adults"},{"title3":"Viral and Mycoplasma pneumoniae community-acquired pneumonia and novel clinical outcome evaluation in ambulatory adult patients in China"},{"title3":"Coronavirus spike proteins in viral entry and pathogenesis"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) in disease pathogenesis"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Dipeptidyl peptidase 4 distribution in the human respiratory tract: implications for the Middle East respiratory syndrome"},{"title3":"Differential expression of the Middle East respiratory syndrome coronavirus receptor in the upper respiratory tracts of humans and dromedary camels"},{"title3":"The multifunctional or moonlighting protein CD26/DPPIV"},{"title3":"Human aminopeptidase N is a receptor for human coronavirus 229E"},{"title3":"Pathogenic influenza viruses and coronaviruses utilize similar and contrasting approaches to control interferon-stimulated gene responses"},{"title3":"Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment"},{"title3":"Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC/2012: implications for disease pathogenesis and clinical manifestation"},{"title3":"Dynamic innate immune responses of human bronchial epithelial cells to severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"SARS-associated coronavirus replication in cell lines"},{"title3":"  . Clinical Management of Severe Acute Respiratory Infection When Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection Is Suspected [Accessed 28 Aug 2017.] Available from URl: http://www.who.int/csr/disease/coronavirus_infections/case-management-ipc/en."},{"title3":"Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome"},{"title3":"The role of laboratory diagnostics in emerging viral infections: the example of the Middle East respiratory syndrome epidemic"},{"title3":"SARS: prognosis, outcome and sequelae"},{"title3":"Clinical epidemiology of bocavirus, rhinovirus, two polyomaviruses and four coronaviruses in HIV-infected and HIV-uninfected South African children"},{"title3":"A prospective hospital-based study of the clinical impact of non-severe acute respiratory syndrome (Non-SARS)-related human coronavirus infection"},{"title3":"Acute renal impairment in coronavirus-associated severe acute respiratory syndrome"},{"title3":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Presentation and outcome of Middle East respiratory syndrome in Saudi intensive care unit patients"},{"title3":"Severe acute respiratory syndrome: radiographic appearances and pattern of progression in 138 patients"},{"title3":"Clinical presentation and outcomes of Middle East respiratory syndrome in the Republic of Korea"},{"title3":"Acute Middle East respiratory syndrome coronavirus: temporal lung changes observed on the chest radiographs of 55 patients"},{"title3":"CT correlation with outcomes in 15 patients with acute Middle East respiratory syndrome coronavirus"},{"title3":"Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines"},{"title3":"Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study"},{"title3":"Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study"},{"title3":"mRNA cap-1 methyltransferase in the SARS genome"},{"title3":"Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus"},{"title3":"Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"Treatment with lopinavir/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset"},{"title3":"Interferon-beta and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays"},{"title3":"The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis"},{"title3":"Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol"},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients"},{"title3":"Coronaviruses - drug discovery and therapeutic options"},{"title3":"Passive transfer of a germline-like neutralizing human monoclonal antibody protects transgenic mice against lethal Middle East respiratory syndrome coronavirus infection"},{"title3":"Blocking of exchange proteins directly activated by cAMP leads to reduced replication of Middle East respiratory syndrome coronavirus"},{"title3":"Inhibition of Middle East respiratory syndrome coronavirus infection by anti-CD26 monoclonal antibody"}]}]}]}